HIV partner notification study in prison
Part of Infections clinical trials.
This study helps people recently diagnosed with HIV in prison inform their partners. If you have been sexually active or shared needles in the year before your current stay, this research may be for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with HIV
- You had sex (penile-vaginal or penile-anal) or shared needles for drug use in the year before you came to prison
- You have been in prison for 5 years or less
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study provides legal support to improve HIV care for people who have recently been released from jail or prison. It helps them stay in treatment and lower their viral load.
This study helps Black men who have sex with men or other key populations who have been involved with the justice system get HIV services and job support. It aims to connect you to care and employment help, especially if you aren't already receiving HIV or PrEP care.
This study offers a long-acting injectable HIV medication (cabotegravir/rilpivirine) to people with HIV who are about to be released from a Maryland prison. The goal is to make it easier to stay on treatment after returning to the community in Baltimore City.
This study helps people with HIV or high risk of HIV who have had substance use problems and are in jail or recently released. It tests a program called SUCCESS-E to support health and reduce drug use.
This study looks at whether making needle and syringe programs easier to use helps more people in prison get clean needles. It's about reducing infection risks for everyone at the participating prisons.
This study tests a program to help men who recently left prison and use injectable drugs start and stick with PrEP, a daily pill that prevents HIV. It aims to improve health and connect them with care.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.